涤痰汤合牵正散加减治疗急性缺血性脑卒中恢复期84例

The clinical effect of Di Tan decoction plus Qian Zheng powder in treating acute ischemic stroke during the process of recovery

目的探讨涤痰汤合牵正散加减治疗急性缺血性脑卒中恢复期的临床疗效,观察和分析其预后。方法 84例急性脑卒中恢复期患者随机分为对照组和观察组各42例,对照组采用常规西医恢复治疗;观察组在对照组基础上应用涤痰汤合牵正散加减治疗。比较两组治疗前后临床效果,采用神经功能缺损程度(AS)评分、肢体功能FM评分,巴氏指数(BI)评估患者状况,并进行中医证候积分评估。结果观察组总有效率为88.10%(37/42),显著高于对照组(P<0.05)。治疗后,两组患者言语蹇涩、舌质淡紫、少气懒言、偏身麻木和半身不遂均低于治疗前,且观察组低于对照组,差异均具有统计学意义(P<0.05);观察组AS评分低于对照组,FM和BI评分均高于对照组,差异均具有统计学意义(P<0.05)。结论涤痰汤合牵正散加减治疗急性缺血性脑卒中恢复期,能够促进患者功能恢复,预后良好。

Objective To understand the clinical effect of Di Tan decoction plus Qian Zheng powder in treating acute ischemic stroke during the process of recovery and predict the prognosis. Method 84 patients with acute cerebral stroke during recovery were randomly divided into a control group（ n = 42） and an experimental group（ n = 42）. The control group was treated with conventional Western medicine recovery treatment,and the observation group used Di Tan Decoction and Qian Zheng Powder or adjustment on the basis of the control group. Two weeks as a treatment period for treatment two continuous periods. To evaluate mainly the treatment effect,the neural function defect degree（ AS）,Limb function FM rating,Barthel Index,patient evaluation and traditional Chinese medicine syndrome integral evaluation. Findings The total effective rate of the experimental group was 88. 10%（ 37 /42）,which was higher than that of the control group 73. 81%（ 31 /42）. The difference was statistically significant（ P〈0. 05）. After treatment,the symptoms such as stammer in speech,partial body numbness and hemiplegia reduced more in the experimental group than in the control group. The difference was statistically significant（ P〈0. 05）. The AS score of the experimental group was lower than that of thecontrol group. The FM and BI scores of the experimental group were higher than those of the control group. The difference was statistically significant（ P〈0. 05）. Conclusion Di Tan decoction combined with Qian Zheng powder as a medicine can effectively treat acute ischemic stroke that occurred during the process of recovery. It can help restore a patient＇s physical functions and engender desirable prognosis.